Skip to main content
OpenTrials
Completed

NCT Number: NCT02126735

Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans

CD36, a protein that facilitates tissue uptake of fat, as a common link between blood fat concentrations and metabolic disease states such as diabetes mellitus. Genetic variants in the CD36 gene are more common in African Americans compared to Whites and it may confer protection against metabolic diseases by altering the amount of fat in the blood.

The purpose of this study is to compare the levels of fat in the blood and to assess endothelial dysfunction among carriers versus non-carriers of the coding SNP, rs3211938 of the CD36 gene after a high fat meal challenge

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Vanderbilt University

Nashville, Tennessee, 37232, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • African American men and women age 18-65 years of age
  • BMI 25-45 kg/m2

Exclusion criteria

  • Diabetes
  • Pregnancy
  • Use of nicotinic acid for dyslipidemia
  • History of nutrient malabsorption
  • Clinically significant hepatic or renal disease, OR serum creatinine or liver function tests > 2times upper limits of normal
  • Symptomatic acute or chronic gallbladder disease
  • Any underlying or acute disease requiring regular medication which could in the principal investigator's opinion possibly pose a threat to the subject or make implementation of the protocol difficult
  • Mental conditions rendering the subject unable to understand the nature, scope and possible consequences of the study
  • Patient unwilling or unable to give informed consent

Treatment and study plan

Primary outcomes

  1. Area Under the Concentration-Time Curve triglycerides levels after high fat meal

    Time frame: Baseline values prior to high fat meal and at 10, 20, 30, 60, 120, 240 & 360 minutes

    We expect that subjects heterozygous for the minor allele of CD36 rs3211938 (G/T) would have an increase of 250 units in the area under the curve for triglycerides which is ~50% of the observed difference between patients with CD36 deficiency and normal controls. Assuming that the common standard deviation is 199, using a two group t-test with a type I error of 0.05, a total of 28 subjects (14 carriers and 14 non-carriers) would provide 90% power to detect a difference in our primary endpoint between carriers versus non-carriers of genotype

Secondary outcomes

  1. percent change in flow mediated dilation at baseline and 4 hours after a high fat meal

    Time frame: Change from baseline in flow mediated dilation at 4 hours after high fal meal

    our primary outcome will be the percent change in flow mediated dilation at baseline and 4 hours after a high fat meal (peak effect). Assuming a conservative estimate of standard deviation of 3.19 our proposed study with a total of 28 subjects (14 carriers and 14 non-carriers) would have at least 80% power with type I error of 0.05 to detect a minimum difference in the mean response of 3.5 %.

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Registry information

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Apr 30, 2014
Registry last updated
Dec 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.